Certified by Founder Lodge
Endogenex
United States - PLYMOUTH, MN
START UP
1 Disclosed Funding Rounds $88,000,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Endogenex, in partnership with Mayo Clinic, aims to revolutionize treatment options for individuals with type 2 diabetes (T2D). Endogenex’s innovations focus on resetting the body’s metaboli
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 26 ,2024 | Series C | $88,000,000 |
Mayo Clinic
Hatteras Venture Partners
Intuitive Ventures
SANTÉ
Longitude Capital
Lumira Ventures
Orlando Health Ventures
Moon Surgical
Centerline Biomedical
Cara Care
De Oro Devices
Luminate Medical
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
WealthAi | $1,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)